FUJIFILM Cellular Dynamics, Inc . served as guest editor for Cell & Gene Therapy Insights’ inaugural AI-focused edition.
Public source
Publisher name
Public post
AI in cell and gene therapy is moving quickly — but where is it actually creating value? I recently had the privilege of serving as guest editor for Cell & Gene Therapy…
Company
FUJIFILM Cellular Dynamics, Inc
The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy.
- Industry
- Biotechnology Research
- Location
- Madison, US
- Company size
- 51–200 employees
About FUJIFILM Cellular Dynamics, Inc
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
See moreLatest activity
Latest activity from FUJIFILM Cellular Dynamics, Inc
4 signals
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc employee Nina Bauer, PhD MBA, EVP, Strategy and Commercial, participated in an interview with Drug Discovery News discussing how iPSCs are advancing toxicity testing, high-throughput screening, organoid development, and advanced therapies.
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc will be attending the 6th Annual iPSC Drug Development Summit in Boston from September 9th and 10th.
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc. is hosting a discussion on September 3, 2026, with the Advanced Therapies Think Tank - AT3.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
ISCT, International Society for Cell & Gene Therapy
ISCT, International Society for Cell & Gene Therapy is spotlighting an updated session from Module 2 of Principles & Applications of Cell Therapy Biomanufacturing Characterization Regulatory returns featuring speakers Bambi Grilley, RPh, CIP, CCRC, CCRP, RAC and Aaron Levine, PhD
Presence & Recognition
FUJIFILM Biotechnologies
FUJIFILM Biotechnologies held an on-demand webinar with BioInsights featuring Principal Scientist Group Lead Andrew Hillhouse discussing validated NGS workflows for AAV biosafety and characterization.
Presence & Recognition
ProBio
ProBio published an article in Drug Discovery News exploring how in vivo CAR-T is reshaping the future of cell therapy manufacturing.
Presence & Recognition
Viralgen
Viralgen published a short-clip interview series featuring insights from Viralgen and TAAV CEO Jimmy V on rare disease and innovative manufacturing.
Presence & Recognition
Form Bio